458 related articles for article (PubMed ID: 28723775)
41. Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still's disease: A prospective cohort study.
Zhang W; Yang T; Zhang H; Xu Y; Yang Q; Liu Q; Gao Y; Wu J; Shao L; Zhang W
Cytokine; 2021 Oct; 146():155642. PubMed ID: 34325118
[TBL] [Abstract][Full Text] [Related]
42. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
[TBL] [Abstract][Full Text] [Related]
43. Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.
Ruscitti P; Cipriani P; Masedu F; Iacono D; Ciccia F; Liakouli V; Guggino G; Carubbi F; Berardicurti O; Di Benedetto P; Valenti M; Triolo G; Valentini G; Giacomelli R
BMC Med; 2016 Dec; 14(1):194. PubMed ID: 27903264
[TBL] [Abstract][Full Text] [Related]
44. The value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as complementary diagnostic tools in the diagnosis of rheumatoid arthritis: A multicenter retrospective study.
Jin Z; Cai G; Zhang P; Li X; Yao S; Zhuang L; Ren M; Wang Q; Yu X
J Clin Lab Anal; 2021 Jan; 35(1):e23569. PubMed ID: 32951253
[TBL] [Abstract][Full Text] [Related]
45. Potential role of adenosine deaminase in the diagnosis of adult-onset Still's disease.
Xun C; Zhao Y; Hu ZJ
Rheumatol Int; 2013 May; 33(5):1255-8. PubMed ID: 23096558
[TBL] [Abstract][Full Text] [Related]
46. sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia.
Colafrancesco S; Priori R; Alessandri C; Astorri E; Perricone C; Blank M; Agmon-Levin N; Shoenfeld Y; Valesini G
Immunol Res; 2014 Dec; 60(2-3):177-83. PubMed ID: 25388964
[TBL] [Abstract][Full Text] [Related]
47. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
48. Neutrophil-derived lipocalin-2 in adult-onset Still's disease: a novel biomarker of disease activity and liver damage.
Jia J; Yang L; Cao Z; Wang M; Ma Y; Ma X; Liu Q; Teng J; Shi H; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Liu T; Wang Z; Wan L; Yang C; Hu Q
Rheumatology (Oxford); 2021 Jan; 60(1):304-315. PubMed ID: 32766690
[TBL] [Abstract][Full Text] [Related]
49. Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis.
Inoue N; Shimizu M; Tsunoda S; Kawano M; Matsumura M; Yachie A
Clin Immunol; 2016 Aug; 169():8-13. PubMed ID: 27263804
[TBL] [Abstract][Full Text] [Related]
50. Identification of prognostic factors and construction of a nomogram for patients with relapse/refractory adult-onset Still's disease.
Yin R; Wang G; Yang X; Zhang L; Wang S; Li T; Liu S
Clin Rheumatol; 2021 Oct; 40(10):3951-3960. PubMed ID: 34002352
[TBL] [Abstract][Full Text] [Related]
51. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
[TBL] [Abstract][Full Text] [Related]
52. Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
Chen X; Hu QY; Wang M; Jia J; Teng J; Sun Y; Cheng X; Ye J; Su Y; Shi H; Chi H; Zhou Z; Liu T; Wang Z; Wan L; Qiao X; Wang F; Wu X; Yang C; Liu HL
Rheumatol Int; 2022 Jan; 42(1):149-157. PubMed ID: 34499196
[TBL] [Abstract][Full Text] [Related]
53. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.
Chen PK; Lan JL; Huang PH; Hsu JL; Chang CK; Tien N; Lin HJ; Chen DY
Front Immunol; 2021; 12():719544. PubMed ID: 34367188
[TBL] [Abstract][Full Text] [Related]
55. The Role of RIPK1/3 in Adult Onset Still's Disease Patients With Liver Damage: A Preliminary Study.
Liu X; Guo R; Meng X; Fang J; Lu L
Front Immunol; 2020; 11():560744. PubMed ID: 33329521
[TBL] [Abstract][Full Text] [Related]
56. Red blood cell distribution width is useful in discriminating adult onset Still's disease and sepsis within 24 hours after hospitalization.
Park HJ; Song J; Park YB; Lee SK; Lee SW
Korean J Intern Med; 2018 Nov; 33(6):1234-1240. PubMed ID: 28838228
[TBL] [Abstract][Full Text] [Related]
57. Platelet parameters aid identification of adult-onset Still's disease from sepsis.
Liu JP; Wang YM; Zhou J
Neth J Med; 2019 Oct; 77(8):274-279. PubMed ID: 31814574
[TBL] [Abstract][Full Text] [Related]
58. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.
Kim HA; Han JH; Kim WJ; Noh HJ; An JM; Yim H; Jung JY; Kim YS; Suh CH
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537874
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
Fautrel B; Le Moël G; Saint-Marcoux B; Taupin P; Vignes S; Rozenberg S; Koeger AC; Meyer O; Guillevin L; Piette JC; Bourgeois P
J Rheumatol; 2001 Feb; 28(2):322-9. PubMed ID: 11246670
[TBL] [Abstract][Full Text] [Related]
60. Clinical features and prognosis of adult-onset still's disease: 61 cases from China.
Zeng T; Zou YQ; Wu MF; Yang CD
J Rheumatol; 2009 May; 36(5):1026-31. PubMed ID: 19273456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
